Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease

NCT03242499 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Lovastatin
DRUG: Placebo

Sponsor

National Taiwan University Hospital